Planet Green Holdings Corp. announced it has entered into commercial operations to source, market, and distribute lactoferrin for health-product applications, including its chewable immune tablets. The company intends to expand its executive team by adding a Chief Scientist role to support scientific investments and new product launches, with a candidate identified but not yet appointed. Lactoferrin is described as a critical glycoprotein used in infant formulas, sports nutrition, and dietary supplements. The target market includes China, which represents 22% of the estimated $300 million in annual global demand today and imports almost all lactoferrin due to limited domestic production capabilities. Planet Green Holdings Corp. operates a diversified portfolio of businesses, including consumer products and online advertising.
